Clinical trial
Diagnostic and Prognosis Value of Circulating DNA for CRC Patients' Surveillance After Curative Treatment
NCT02813928 is registered in ClinicalTrials.gov with University Hospital, Limoges as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Diagnostic and Prognosis Value of Circulating DNA for CRC Patients' Surveillance After Curative Treatment
- Lead sponsor
- University Hospital, Limoges
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- July 31, 2016
- Completion date
- July 31, 2022
- Enrollment
- 473 (actual)
- Sites
- 19
Conditions
As the registry lists them; a condition with its own page is linked.
colorectal cancer